| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = -$97,215 ) |
| | 2026 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | K99HL174827 | COMPLEMENT IN THE CELLULAR MICROENVIRONMENT DURING CARDIAC RENEWAL | 000 | 2 | NIH | 5/5/2026 | -$97,215 |
| | 2026 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL177644 | Senescent Cell States in Single Ventricle Disease with Heart Failure | 000 | 1 | NIH | 3/9/2026 | $0 |
| | 2026 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL179012 | Targeting Senescent Macrophages to Improve Heart Failure Outcomes | 000 | 1 | NIH | 5/5/2026 | $0 |
| | 2026 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL177644 | Senescent Cell States in Single Ventricle Disease with Heart Failure | 002 | 1 | NIH | 4/13/2026 | $0 |
| | 2026 | 2024 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R61HL168737 | Targeting Integrin Signaling in Atherosclerosis | 000 | 2 | NIH | 3/16/2026 | $0 |
| | 2026 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL153538 | Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility | 000 | 4 | NIH | 2/6/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $3,012,954 ) |
| | 2025 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL166724 | Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility | 000 | 3 | NIH | 7/23/2025 | $683,158 |
| | 2025 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R33HL168737 | Targeting Integrin Signaling in Atherosclerosis | 000 | 3 | NIH | 7/2/2025 | $534,347 |
| | 2025 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL179012 | Targeting Senescent Macrophages to Improve Heart Failure Outcomes | 000 | 1 | NIH | 7/23/2025 | $651,967 |
| | 2025 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL169632 | Coordinated Heart Stimulation Testbed: A Platform for Contractile Ventricle Engineering | 000 | 3 | NIH | 5/9/2025 | $390,945 |
| | 2025 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | K99HL174827 | COMPLEMENT IN THE CELLULAR MICROENVIRONMENT DURING CARDIAC RENEWAL | 000 | 2 | NIH | 7/10/2025 | $97,216 |
| | 2025 | 2025 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL177644 | Senescent Cell States in Single Ventricle Disease with Heart Failure | 000 | 1 | NIH | 12/30/2024 | $655,636 |
| | 2025 | 2024 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R61HL168737 | Targeting Integrin Signaling in Atherosclerosis | 000 | 2 | NIH | 2/19/2025 | $0 |
| | 2025 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R33HL161778 | Optimization of small molecule integrin activators to enhance cord blood transplant | 000 | 2 | NIH | 5/28/2025 | $0 |
| | 2025 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL127717 | Hippo and Wnt Signaling in Cardiac Regeneration | 000 | 8 | NIH | 5/6/2025 | -$293 |
| | 2025 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL144683 | Leadless wirelessly powered pacemaker for multi chamber pacing using miniaturized pacing and sensing node | 000 | 4 | NIH | 12/16/2024 | -$22 |
|
| Issue Date FY: 2024 ( Subtotal = $1,767,250 ) |
| | 2024 | 2024 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL169632 | Coordinated Heart Stimulation Testbed: A Platform for Contractile Ventricle Engineering | 000 | 2 | NIH | 6/27/2024 | $432,503 |
| | 2024 | 2024 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL166724 | Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility | 000 | 2 | NIH | 6/7/2024 | $680,982 |
| | 2024 | 2024 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | K99HL174827 | Complement in the cellular microenvironment during cardiac renewal | 000 | 1 | NIH | 7/8/2024 | $97,216 |
| | 2024 | 2024 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R61HL168737 | Targeting Integrin Signaling in Atherosclerosis | 000 | 2 | NIH | 6/6/2024 | $556,549 |
| | 2024 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R61HL168737 | Targeting Integrin Signaling in Atherosclerosis | 001 | 1 | NIH | 8/2/2024 | $0 |
| | 2024 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL144683 | Leadless wirelessly powered pacemaker for multi chamber pacing using miniaturized pacing and sensing node | 000 | 4 | NIH | 11/13/2023 | $0 |
| | 2024 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R24OD033737 | Establishing Automated Cryopreservation System for Biospecimen Storage | 000 | 1 | NIH | 4/1/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $3,652,411 ) |
| | 2023 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R01HL153538 | Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility | 000 | 4 | NIH | 6/3/2023 | $787,884 |
| | 2023 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R01HL166724 | Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility | 000 | 1 | NIH | 6/29/2023 | $752,493 |
| | 2023 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R33HL161778 | Optimization of small molecule integrin activators to enhance cord blood transplant | 001 | 2 | NIH | 2/1/2023 | $0 |
| | 2023 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R33HL161778 | Optimization of small molecule integrin activators to enhance cord blood transplant | 000 | 2 | NIH | 1/20/2023 | $547,028 |
| | 2023 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R61HL168737 | Targeting Integrin Signaling in Atherosclerosis | 000 | 1 | NIH | 5/25/2023 | $572,082 |
| | 2023 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R01HL169632 | Coordinated Heart Stimulation Testbed: A Platform for Contractile Ventricle Engineering | 000 | 1 | NIH | 5/24/2023 | $404,238 |
| | 2023 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R01HL127717 | Hippo and Wnt Signaling in Cardiac Regeneration | 001 | 8 | NIH | 3/15/2023 | $58,869 |
| | 2023 | 2023 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R01HL127717 | Hippo and Wnt Signaling in Cardiac Regeneration | 000 | 8 | NIH | 1/2/2023 | $529,817 |
| | 2023 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL144683 | Leadless wirelessly powered pacemaker for multi chamber pacing using miniaturized pacing and sensing node | 001 | 4 | NIH | 9/2/2023 | $0 |
| | 2023 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R01HL144683 | Leadless wirelessly powered pacemaker for multi chamber pacing using miniaturized pacing and sensing node | 000 | 4 | NIH | 11/2/2022 | $0 |
| | 2023 | 2020 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030-2604 | HARRIS | USA | R21HL144244 | Using a Cardiac Microtissue System to Evaluate and Replicate Clinical Therapy Responses using Patient Cell-Derived Exosomes | 000 | 2 | NIH | 11/10/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $3,238,230 ) |
| | 2022 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE MC3 117 | HOUSTON | TX | 77030 | HARRIS | USA | R01HL127717 | Hippo and Wnt Signaling in Cardiac Regeneration | 001 | 7 | NIH | 6/29/2022 | $58,869 |
| | 2022 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE MC3 117 | HOUSTON | TX | 77030 | HARRIS | USA | R01HL153538 | Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility | 000 | 3 | NIH | 7/7/2022 | $687,156 |
| | 2022 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE MC3 117 | HOUSTON | TX | 77030-2604 | HARRIS | USA | R01HL127717 | Hippo and Wnt Signaling in Cardiac Regeneration | 000 | 7 | NIH | 1/14/2022 | $529,817 |
| | 2022 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE MC3 117 | HOUSTON | TX | 77030 | HARRIS | USA | R01HL144683 | Leadless wirelessly powered pacemaker for multi chamber pacing using miniaturized pacing and sensing node | 000 | 4 | NIH | 8/19/2022 | $607,994 |
| | 2022 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE MC3 117 | HOUSTON | TX | 77030 | HARRIS | USA | R33HL161778 | Optimization of small molecule integrin activators to enhance cord blood transplant | 001 | 1 | NIH | 5/17/2022 | $0 |
| | 2022 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE MC3 117 | HOUSTON | TX | 77030 | HARRIS | USA | R33HL161778 | Optimization of small molecule integrin activators to enhance cord blood transplant | 000 | 1 | NIH | 2/15/2022 | $547,028 |
| | 2022 | 2022 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE MC3 117 | HOUSTON | TX | 77030 | HARRIS | USA | R24OD033737 | Establishing Automated Cryopreservation System for Biospecimen Storage | 000 | 1 | NIH | 8/16/2022 | $220,814 |
| | 2022 | 2019 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | R03NS110442 | A Patient-Specific Analysis Framework for Assessing Stroke Risk in Pediatric Moyamoya Disease | 000 | 2 | NIH | 3/17/2022 | $0 |
| | 2022 | 2018 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | UM1HL087365 | Cardiovascular Cell Therapy Research Network | 001 | 12 | NIH | 12/22/2021 | $669,043 |
| | 2022 | 2018 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | UM1HL087365 | Cardiovascular Cell Therapy Research Network | 002 | 12 | NIH | 6/27/2022 | -$320,872 |
| | 2022 | 2017 | TEXAS HEART INSTITUTE | 6770 BERTNER AVE | HOUSTON | TX | 77030 | HARRIS | USA | UM1HL087365 | Cardiovascular Cell Therapy Research Network | 000 | 11 | NIH | 12/22/2021 | $238,381 |
|
|
